Product Information
Clinic Support
Client Information
Technical Information

Feline UltraNasal® FVRCP Vaccine

Description and General Information:

Feline Rhinotracheitis-Calici-Panleukopenia Vaccine, MLV is designed for intranasal administration. Each of the viruses is widespread and are common disease causing agents of cats.

Indications:

Recommended for the vaccination of healthy cats and kittens at least 12 weeks of age for the prevention of disease due to feline herpesvirus-1 (the cause of feline rhinotracheitis) and as an aid in the prevention of disease due to feline calicivirus and feline parvovirus (the cause of feline panleukopenia). Cats can be vaccinated with a single dose at 12 weeks of age. If cats are vaccinated at less than 12 weeks of age, a second vaccination should be administered at 12-16 weeks of age. Annual revaccination is recommended.

Precautions:

Store out of direct sunlight at a temperature between 35° F – 45° F (2° C – 7° C). Use the entire contents of the vial when first opened. Do not vaccinate pregnant animals. Do not use in kittens younger than 4 weeks of age. Burn containers and all unused contents.

In rare instances, reactions can occur due to unusual sensitivity following use of this product. In such cases, administer epinephrine as an antidote. The vaccine will not protect against disease in the face of incubating feline herpesvirus, feline calicivirus or feline parvovirus infection. Therefore, only healthy cats should be considered as candidates for vaccination.

Transient sneezing for one or more days after vaccination is not uncommon. A small number of cats may experience other mild post-vaccination side effects including ocular and/or nasal discharge, GI signs (such as vomiting) or, in rare instances, nasal or oral ulcers. A transient slight drop in the white blood cell count has been noted at times after vaccination. These signs are usually mild and clear without treatment.

Contains gentamicin and nystatin as preservatives.

Dosage

and Administration: Administer a single 0.2 ml dose intranasally, divided into both nostrils. NOTE: Use a new dropper for each cat vaccinated. No needles are necessary to administer the vaccine. This vaccine is NOT intended for intramuscular or subcutaneous injection.

Administer a single 0.2 ml dose intranasally, divided into both nostrils.

STEP 1: Remove the cap and rubber stopper from one vial of liquid vaccine and one vial of lyophilized vaccine.
STEP 2: Using the nasal dropper, transfer the liquid vaccine (0.2 ml) to the lyophilized vaccine vial.
STEP 3: Mix the vaccine in the vial with a gentle swirling motion.
STEP 4: Once dissolved, immediately withdraw the rehydrated vaccine into the nasal dropper.
STEP 5: Vaccinate the cat by placing the vaccine equally in each nostril. Avoid touching the nose with the dropper.